Efficacy of IV Ketamine in Refractory/Super-Refractory Status Epilepticus: A Systematic Review and Meta-Analysis

Background and Objectives Intravenous ketamine is increasingly used for refractory and super-refractory status epilepticus(RSE/ SRSE), yet its efficacy and optimal use remain uncertain. We therefore aimed to synthesize the available evidence to quantify the effectiveness of ketamine in achieving...

Full description

Saved in:
Bibliographic Details
Main Authors: Abhijit Vijay, Lele, Alex, Raquer, Jorge, Mejia-Mantil, Samuel Tsan, Ern Hung, Gentle Sunder, Shrestha, Victor, Lin, Samuel Neal, Blacker, Sean, Marinelli, Peter Chee Seong, Tan, Sarah, Wahlster, Andres, Gempeler
Format: Article
Language:en
Published: American Academy of Neurology 2026
Subjects:
Online Access:http://ir.unimas.my/id/eprint/51372/3/Efficacy%20of%20IV%20Ketamine%20in%20Refractory%20-%20Copy.pdf
http://ir.unimas.my/id/eprint/51372/
https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200584
https://doi.org/10.1212/CPJ.0000000000200584
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives Intravenous ketamine is increasingly used for refractory and super-refractory status epilepticus(RSE/ SRSE), yet its efficacy and optimal use remain uncertain. We therefore aimed to synthesize the available evidence to quantify the effectiveness of ketamine in achieving seizure cessation and to explore differences in treatmentcharacteristics between patients who respond and those who do not. Methods We conducted a systematic review and meta-analysis to estimate the pooled seizure cessation rate associated with intravenous ketamine. Secondary analyses compared ketamine initiation timing, dosing, and infusion duration between patients who achieved seizure cessation (responders) and those who did not (nonresponders).